WATER INDUSTRY FEATURES, INSIGHTS, AND ANALYSIS
-
EPA Seeks Court‑Ordered Removal Of 4 PFAS Limits
The U.S. EPA is testing a new procedural strategy to remove four PFAS drinking‑water limits from ongoing litigation, asking the D.C. Circuit Court of Appeals to invalidate those limits on the grounds that the EPA itself committed a procedural misstep when issuing the 2024 PFAS rule.
-
Putting The National Toxicology Program's Fluoride Review In Context Despite renewed public concern over fluoride and cognition, the National Toxicology Program’s findings focus on high‑fluoride groundwater conditions — not the controlled levels used in U.S. drinking water systems. Understanding that distinction is critical for utilities navigating policy questions and community expectations.
-
Opinion: Why PFAS Policymakers Should Read Past The Abstract When it comes to drinking water, sound public policy requires sound scientific research. Publication in a prestigious, peer-reviewed journal helps establish legitimacy for scientific claims in public discourse. But science is a social process, scientific standards of evidence vary across disciplines, and peer review does not guarantee validity. For readers who stop at the abstract, these distinctions can be easy to miss.
-
Planting The Seeds Of Inspiration: Eelgrass Restoration
Restoring eelgrass beds is critical because they provide habitat for many kinds of marine life, improve water quality by filtering out pollution, and the plant’s root system stabilizes the sediment on the seafloor, protecting shorelines from erosion.
-
PFAS Are Turning Up In The Great Lakes, Putting Water Supplies At Risk — Here's How They Get There No matter where you live in the U.S., you have likely seen headlines about PFAS being detected in everything from drinking water to fish to milk to human bodies. Now, PFAS are posing a threat to the Great Lakes, one of America’s most vital water resources.
-
Why Too Much Phosphorus In America's Farmland Is Polluting The Country's Water When people think about agricultural pollution, they often picture what is easy to see: fertilizer spreaders crossing fields or muddy runoff after a heavy storm. However, a much more significant threat is quietly and invisibly building in the ground.
-
Water In 2026: The Nexus Of Policy, Technology, And Resilience As water systems become more circular and complex, understanding and managing the subsurface — the hidden half of the water cycle — is becoming a critical enabler of resilience. This article explores the key trends shaping this new reality, from tackling “forever chemicals” to the water strategies redefining heavy industry.
-
PFAS In Pregnant Women's Drinking Water Puts Their Babies At Higher Risk, Study Finds
When pregnant women drink water that comes from wells downstream of sites contaminated with PFAS, known as “forever chemicals,” the risks to their babies’ health substantially increase, a new study found. These risks include the chance of low birth weight, preterm birth, and infant mortality.
-
PFAS Settlements: Debunking The Myths And Revealing What's Really At Stake For Water Utilities Misinformation and confusion could prevent some utilities from benefitting from the aqueous film-forming foam multidistrict litigation (AFFF MDL) settlements. Here are five common myths about the AFFF MDL PFAS settlements and how public water systems can make the most of this unprecedented funding opportunity.
-
When Chemistry Meets Water Innovation
Nobel-winning molecular materials are poised to reinvent purification, desalination, and reuse.
VIEWS ON THE LATEST REGS
-
Despite renewed public concern over fluoride and cognition, the National Toxicology Program’s findings focus on high‑fluoride groundwater conditions — not the controlled levels used in U.S. drinking water systems. Understanding that distinction is critical for utilities navigating policy questions and community expectations.
-
In this Q&A, Dr. Elke Süss of Metrohm addresses the urgent need for haloacetic acid testing in response to “one of the most significant updates to EU drinking water monitoring in recent years.”
-
With the U.S. EPA's PFAS rules now in place, utilities are finding themselves with a growing number of questions regarding how to treat these chemicals, the potential costs, and much more. For answers, Water Online's chief editor, Kevin Westerling, hosted an Ask Me Anything session featuring Ken Sansone, Senior Partner at SL Environmental Law Group; Kyle Thompson, National PFAS Lead at Carollo Engineers; and Lauren Weinrich, Principal Scientist at American Water.
-
A Q&A to explain and resolve issues confronting water suppliers as they endeavor to comply with the monitoring requirements of federal PFAS regulations.
-
Assessing what lies ahead in the 10-year race to go lead-free, otherwise known as the Lead and Copper Rule Improvements (LCRI).
MORE WATER INDUSTRY FEATURES
-
The evolving field of viral vector production, driven by advances in gene and cell therapies, is facing increasing regulatory scrutiny and analytical demands.
-
High‑concentration biologic formulations for prefilled syringes and on‑body devices enable easier self‑administration, reduce treatment burden, boost adherence, and address complex formulation challenges.
-
Choosing the right incubator requires more than reading specs. Learn how to evaluate performance metrics, contamination control, and real-world functionality to make confident equipment decisions.
-
Achieving compliance and safety through Disinfectant Efficacy Studies (DES) is about adhering to regulations and committing to high standards of safety and quality of manufacturing operations.
-
Multi-well inserts allowing for a two-chamber system that can expose cell cultures from above and below provide greater versatility and expand research options compared to standard cell culture plates.
-
Discover a robust, evaporation-free method for analyzing liraglutide in human plasma using LC-MS/MS to ensure high sensitivity, reproducibility, and improved analyte recovery.
-
Clinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.
-
Nanobubble physics enable higher ozone stability and mass transfer efficiency in water. Discover how the negative surface charge of these microstructures improves localized oxidation and penetration into difficult matrices.
-
Though new EPA regulations are set to enforce stricter limits on PFAS in drinking water by 2029, millions of students are already attending schools in areas with elevated risk today.
-
Product Carbon Footprints reveal true lifecycle emissions, enabling collaboration, innovation, and informed decisions. Learn why moving from estimates to evidence is essential for reducing Scope 3 impact.
-
Learn how scanners used for high resolution metrology measurements should be designed and tested for flatness of motion, particularly for atomic force microscopy (AFM).
-
With tox material in hand as soon as possible, antibody-derived drug developers can conduct their tox studies earlier, facilitating a timely IND submission and speeding up pathways to patients.
-
Discover common pitfalls in cell washing and pre-formulation, including incomplete contaminant removal, manual handling, and throughput issues that compromise product quality and efficiency.
-
Explore how PFAS in medical devices pose environmental and health concerns, prompting regulatory scrutiny.
-
X-band radar advancements, powered by BFICs, GaN, and GaAs, are enhancing drone detection, surveillance, and defense applications. Qorvo’s innovations provide high-performance, cost-effective solutions for modern security challenges.
-
Learn why the U.S. EPA has recognized granular activated carbon (GAC) as a best available technology (BAT) for a wide range of substances within the same system.
-
Flat-rate clinical trial payments are often taxable in the U.S., while reimbursements are not. Unclear tax rules can impact participant trust, site communication, and trial retention.
-
Ensuring adequate solubility is crucial for small molecule drugs' effectiveness. Find out how poor solubility remains a significant challenge, potentially hindering medications from reaching the market.